WPI 3154 (Modafinil 100 mg)
Pill with imprint WPI 3154 is White, Capsule-shape and has been identified as Modafinil 100 mg. It is supplied by Watson Laboratories, Inc..
Modafinil is used in the treatment of shift work sleep disorder; narcolepsy; obstructive sleep apnea/hypopnea syndrome and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Modafinil 100 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).
Images for WPI 3154
Modafinil
- Imprint
- WPI 3154
- Strength
- 100 mg
- Color
- White
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Cns stimulants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 4 - Some potential for abuse
- Labeler / Supplier
- Watson Laboratories, Inc.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00591-3499 | Watson Pharmaceuticals, Inc. |
| 42291-0599 | AvKare, Inc. |
| 00904-6423 | Major Pharmaceuticals |
More about modafinil
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 405 Reviews
- Drug class: CNS stimulants
- FDA Alerts (1)
Consumer resources
- Other brands
- Provigil
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.